Currently Vice President of Biostatistics & Data Management for Genomic Health, Dr. Whitmore oversees support of genomics-based diagnostic tests that address early-stage cancer. Previously with Juno Therapeutics as Vice President of Biometrics for Juno Therapeutics, Dr. Whitmore oversaw support of cellular immunotherapy products in hematologic oncology, including biostatistics, statistical programming and data management. Dr. Whitmore earned his MS and PhD in Statistics from Colorado State University.

Dr. Donahue has extensive experience in every phase of drug development and has served in lead statistical roles in research and development for products in allergy, analgesia, epilepsy, schizophrenia, Alzheimer’s disease, depression, addiction, surgery, orthopedics, and other areas. Dr. Donahue serves on the editorial board of the journal, Therapeutic Innovation & Regulatory Science. Dr. Donahue earned his BS in Mathematics from the University of Dayton and his PhD in Statistics from Colorado State University.